Literature DB >> 27160294

Mouse Model of Coxiella burnetii Aerosolization.

Cléa Melenotte1,2, Hubert Lepidi1, Claude Nappez1, Yassina Bechah1, Gilles Audoly1, Jérôme Terras1, Didier Raoult1,2, Fabienne Brégeon3,4.   

Abstract

Coxiella burnetii is mainly transmitted by aerosols and is responsible for multiple-organ lesions. Animal models have shown C. burnetii pathogenicity, but long-term outcomes still need to be clarified. We used a whole-body aerosol inhalation exposure system to mimic the natural route of infection in immunocompetent (BALB/c) and severe combined immunodeficient (SCID) mice. After an initial lung inoculum of 10(4) C. burnetii cells/lung, the outcome, serological response, hematological disorders, and deep organ lesions were described up to 3 months postinfection. C. burnetii-specific PCR, anti-C. burnetii immunohistochemistry, and fluorescent in situ hybridization (FISH) targeting C. burnetii-specific 16S rRNA completed the detection of the bacterium in the tissues. In BALB/c mice, a thrombocytopenia and lymphopenia were first observed, prior to evidence of C. burnetii replication. In all SCID mouse organs, DNA copies increased to higher levels over time than in BALB/c ones. Clinical signs of discomfort appeared in SCID mice, so follow-up had to be shortened to 2 months in this group. At this stage, all animals presented bone, cervical, and heart lesions. The presence of C. burnetii could be attested in situ for all organs sampled using immunohistochemistry and FISH. This mouse model described C. burnetii Nine Mile strain spread using aerosolization in a way that corroborates the pathogenicity of Q fever described in humans and completes previously published data in mouse models. C. burnetii infection occurring after aerosolization in mice thus seems to be a useful tool to compare the pathogenicity of different strains of C. burnetii.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27160294      PMCID: PMC4936361          DOI: 10.1128/IAI.00108-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Application of fluorescent in situ hybridisation for demonstration of Coxiella burnetii in placentas from ruminant abortions.

Authors:  Tim K Jensen; Donald L Montgomery; Paula T Jaeger; Tina Lindhardt; Jørgen S Agerholm; Vivi Bille-Hansen; Mette Boye
Journal:  APMIS       Date:  2007-04       Impact factor: 3.205

2.  Multiple "doughnut" granulomas in Coxiella burnetii infection (Q fever).

Authors:  Grant Herndon; Heesun J Rogers
Journal:  Blood       Date:  2013-10-31       Impact factor: 22.113

3.  Comparison between emerging Q fever in French Guiana and endemic Q fever in Marseille, France.

Authors:  Sophie Edouard; Aba Mahamat; Magalie Demar; Philippe Abboud; Felix Djossou; Didier Raoult
Journal:  Am J Trop Med Hyg       Date:  2014-03-17       Impact factor: 2.345

4.  Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology.

Authors:  R I Amann; L Krumholz; D A Stahl
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

5.  Route of infection determines the clinical manifestations of acute Q fever.

Authors:  T J Marrie; A Stein; D Janigan; D Raoult
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

6.  Coxiella burnetii associated placental lesions and infection level in parturient cows.

Authors:  Mette S Hansen; Annie Rodolakis; Denis Cochonneau; Jens F Agger; Anna-Bodil Christoffersen; Tim K Jensen; Jørgen S Agerholm
Journal:  Vet J       Date:  2011-02-02       Impact factor: 2.688

7.  Repeated pregnancies in BALB/c mice infected with Coxiella burnetii cause disseminated infection, resulting in stillbirth and endocarditis.

Authors:  A Stein; H Lepidi; J L Mege; T J Marrie; D Raoult
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

8.  Spread and distribution of Coxiella burnetii in C57BL/6J (H-2b) and Balb/cJ (H-2d) mice after intraperitoneal infection.

Authors:  W Baumgärtner; H Dettinger; N Schmeer
Journal:  J Comp Pathol       Date:  1993-02       Impact factor: 1.311

9.  Valvular endocarditis occurs as a part of a disseminated Coxiella burnetii infection in immunocompromised BALB/cJ (H-2d) mice infected with the nine mile isolate of C. burnetii.

Authors:  E Atzpodien; W Baumgärtner; A Artelt; D Thiele
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

10.  Coxiella burnetii interaction with neutrophils and macrophages in vitro and in SCID mice following aerosol infection.

Authors:  Alexandra Elliott; Ying Peng; Guoquan Zhang
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

View more
  8 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.

Authors:  A E Gregory; E J van Schaik; K E Russell-Lodrigue; A P Fratzke; J E Samuel
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

3.  Characterization of Coxiella burnetii strains from ruminants in a Galleria mellonella host-based model.

Authors:  A Selim; E Yang; E Rousset; R Thiéry; K Sidi-Boumedine
Journal:  New Microbes New Infect       Date:  2018-03-02

4.  Pathologic changes and immune responses against Coxiella burnetii in mice following infection via non-invasive intratracheal inoculation.

Authors:  Xueyuan Hu; Yonghui Yu; Junxia Feng; Mengjiao Fu; Lupeng Dai; Zhiyu Lu; Wenbo Luo; Jinglin Wang; Dongsheng Zhou; Xiaolu Xiong; Bohai Wen; Baohua Zhao; Jun Jiao
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

Review 5.  Preclinical Animal Models for Q Fever Vaccine Development.

Authors:  Mahelat Tesfamariam; Picabo Binette; Carrie Mae Long
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

6.  Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.

Authors:  M Gill Hartley; Isobel H Norville; Mark I Richards; Kay B Barnes; Kevin R Bewley; Julia Vipond; Emma Rayner; Andreas Vente; Stuart J Armstrong; Sarah V Harding
Journal:  Front Microbiol       Date:  2021-11-30       Impact factor: 5.640

Review 7.  Coxiella burnetii Lipopolysaccharide: What Do We Know?

Authors:  Prasad Abnave; Xavier Muracciole; Eric Ghigo
Journal:  Int J Mol Sci       Date:  2017-11-23       Impact factor: 5.923

8.  Clinical Features and Complications of Coxiella burnetii Infections From the French National Reference Center for Q Fever.

Authors:  Cléa Melenotte; Camélia Protopopescu; Matthieu Million; Sophie Edouard; M Patrizia Carrieri; Carole Eldin; Emmanouil Angelakis; Félix Djossou; Nathalie Bardin; Pierre-Edouard Fournier; Jean-Louis Mège; Didier Raoult
Journal:  JAMA Netw Open       Date:  2018-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.